MYLIFE Trial
The trial is hypothesised to reduce metabolic syndrome risk more in intervention groups than in the control group at the primary endpoint. MYLIFE compares routine health management with smartphone-only and stratified smartphone-plus-wearab…
1 sources - 4 claims
The trial is hypothesised to reduce metabolic syndrome risk more in intervention groups than in the control group at the primary endpoint. MYLIFE compares routine health management with smartphone-only and stratified smartphone-plus-wearable mHealth strategies.